Cargando…
ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
BACKGROUND: Individuals with type 1 diabetes (T1D) have a two- to threefold increase in fracture risk at any site, and up to a sevenfold increase in hip fracture risk compared to those without diabetes. Reduced bone quality appears to contribute to the increased fracture risk observed in this popula...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624666/ http://dx.doi.org/10.1210/jendso/bvac150.368 |
_version_ | 1784822289271881728 |
---|---|
author | Coll, Julie-Catherine Garceau, Élodie Leslie, William D Michou, Laëtitia John Weisnagel, S Mac-Way, Fabrice Morin, Suzanne N Rabasa-Lhoret, Rémi Gagnon, Claudia |
author_facet | Coll, Julie-Catherine Garceau, Élodie Leslie, William D Michou, Laëtitia John Weisnagel, S Mac-Way, Fabrice Morin, Suzanne N Rabasa-Lhoret, Rémi Gagnon, Claudia |
author_sort | Coll, Julie-Catherine |
collection | PubMed |
description | BACKGROUND: Individuals with type 1 diabetes (T1D) have a two- to threefold increase in fracture risk at any site, and up to a sevenfold increase in hip fracture risk compared to those without diabetes. Reduced bone quality appears to contribute to the increased fracture risk observed in this population. Advanced glycation end products (AGEs) tissue accumulation, which reflects long-term glycemic control, may influence bone quality in T1D. OBJECTIVE: We aimed to determine if skin AGEs, as a surrogate marker for bone AGEs, are associated with vertebral trabecular bone score (TBS),anindex of bone microarchitecture derived from lumbar spine dual-energy X-ray absorptiometry (DXA) images and evaluating bone quality. METHODS: We present preliminary data from subjects with T1D who participated in a cross-sectional study aiming at comparing the prevalence of vertebral fractures between adult subjects with T1D from two tertiary care centers and age-, sex- and BMI-matched controls without diabetes. TBS and bone mineral density (BMD) were assessed using DXA. Skin AGEs were measured by skin autofluorescence. Simple and multiple linear regression analyses were used to explore the factors associated with TBS. RESULTS: One hundred and six subjects with T1D (52.8% women; mean age 42.7±14.7 years; mean BMI 26.9±5.6 kg/m 2; mean diabetes duration 27.6±12.3 years; 48.1% with a microvascular complication; mean HbA 1C in the preceding 3 years 7.5±0.9%; mean skin AGEs 2.15±0.54 units; mean TBS 1.428±0.113) were included. Higher skin AGEs were associated with a lower TBS in simple regression analysis (p=0. 012). In multiple linear regression, older age, male sex, higher BMI, current smoking, higher serum calcium, lower lumbar spine and femoral neck BMD, but not skin AGEs, were significantly associated with a lower TBS (model adjusted R 2 =0.65). CONCLUSION: In this population with relatively well-controlled T1D, skin AGEs were not independently associated with TBS. Presentation: No date and time listed |
format | Online Article Text |
id | pubmed-9624666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96246662022-11-14 ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes Coll, Julie-Catherine Garceau, Élodie Leslie, William D Michou, Laëtitia John Weisnagel, S Mac-Way, Fabrice Morin, Suzanne N Rabasa-Lhoret, Rémi Gagnon, Claudia J Endocr Soc Bone & Mineral Metabolism BACKGROUND: Individuals with type 1 diabetes (T1D) have a two- to threefold increase in fracture risk at any site, and up to a sevenfold increase in hip fracture risk compared to those without diabetes. Reduced bone quality appears to contribute to the increased fracture risk observed in this population. Advanced glycation end products (AGEs) tissue accumulation, which reflects long-term glycemic control, may influence bone quality in T1D. OBJECTIVE: We aimed to determine if skin AGEs, as a surrogate marker for bone AGEs, are associated with vertebral trabecular bone score (TBS),anindex of bone microarchitecture derived from lumbar spine dual-energy X-ray absorptiometry (DXA) images and evaluating bone quality. METHODS: We present preliminary data from subjects with T1D who participated in a cross-sectional study aiming at comparing the prevalence of vertebral fractures between adult subjects with T1D from two tertiary care centers and age-, sex- and BMI-matched controls without diabetes. TBS and bone mineral density (BMD) were assessed using DXA. Skin AGEs were measured by skin autofluorescence. Simple and multiple linear regression analyses were used to explore the factors associated with TBS. RESULTS: One hundred and six subjects with T1D (52.8% women; mean age 42.7±14.7 years; mean BMI 26.9±5.6 kg/m 2; mean diabetes duration 27.6±12.3 years; 48.1% with a microvascular complication; mean HbA 1C in the preceding 3 years 7.5±0.9%; mean skin AGEs 2.15±0.54 units; mean TBS 1.428±0.113) were included. Higher skin AGEs were associated with a lower TBS in simple regression analysis (p=0. 012). In multiple linear regression, older age, male sex, higher BMI, current smoking, higher serum calcium, lower lumbar spine and femoral neck BMD, but not skin AGEs, were significantly associated with a lower TBS (model adjusted R 2 =0.65). CONCLUSION: In this population with relatively well-controlled T1D, skin AGEs were not independently associated with TBS. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9624666/ http://dx.doi.org/10.1210/jendso/bvac150.368 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Bone & Mineral Metabolism Coll, Julie-Catherine Garceau, Élodie Leslie, William D Michou, Laëtitia John Weisnagel, S Mac-Way, Fabrice Morin, Suzanne N Rabasa-Lhoret, Rémi Gagnon, Claudia ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes |
title | ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes |
title_full | ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes |
title_fullStr | ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes |
title_full_unstemmed | ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes |
title_short | ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes |
title_sort | odp127 trabecular bone score and advanced glycation end products in adults with type 1 diabetes |
topic | Bone & Mineral Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624666/ http://dx.doi.org/10.1210/jendso/bvac150.368 |
work_keys_str_mv | AT colljuliecatherine odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT garceauelodie odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT lesliewilliamd odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT michoulaetitia odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT johnweisnagels odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT macwayfabrice odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT morinsuzannen odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT rabasalhoretremi odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes AT gagnonclaudia odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes |